It may also be regulated by lncRNA ZFAS1, whereas ABCG2 high expression presenting CRC subgroup may be resistant to the anti-EGFR therapy, demonstrating higher proteolytical activity and actin-filament-related activity, thus higher ability to invade surrounding tissue. This evidence concerns the gene EGFR and colorectal carcinoma.